Cleared Traditional

K151693 - Dr-Ho's Foot Pad Electrode

K151693 is an FDA 510(k) clearance for Dr-Ho's Foot Pad Electrode, manufactured by Drtv Asia, Ltd.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K151693 · Drtv Asia, Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
108d
Days
Class 2
Risk

K151693 is an FDA 510(k) clearance for the Dr-Ho's Foot Pad Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Drtv Asia, Ltd. (Panyu, CN). The FDA issued a Cleared decision on October 9, 2015 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K151693

510(k) Number K151693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2015
Decision Date October 09, 2015
Days to Decision 108 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 149d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Media Trade Corporation
GUENTER GINSBERG

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 358
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K151693.
Disposable Adhesive Surface Electrodes, Disposable/Reusable Cup Electrodes
K153019 · Bio Protech, Inc. · Mar 2016
Mailuokang Self-adhesive Electrode
K152815 · Shenzhen Mailuokang Technology Co., Ltd. · Mar 2016
Ennova Self-adhesive Electrode
K152648 · Suzhou Ennova Electronics Technology Co.,Ltd · Feb 2016
Neon EEG
K151576 · Incereb, Ltd. · Sep 2015
Zekang Self-adhesive Electrode
K150971 · Jiangsu Zekang Medical Technology Co., Ltd. · Aug 2015
Philips Self-Adhesive Electrodes
K151033 · Philips Consumer Lifestyle · Jul 2015